Patent ID: 8436026

Claim:
A method of treating diseases, said diseases selected from the group consisting of: ischemic organ disease selected from the group consisting of arteriosclerosis obliterans and cerebral infarction; liver disease selected from the group consisting of fluminant hepatitis, acute hepatitis and fatty liver; kidney disease selected from the group consisting of acute renal insufficiency and chronic renal insufficiency; pancreas disease selected from the group consisting of diabetes mellitus and chronic pancreatitis; digestive organ disease selected from the group consisting of duodenal ulcer; nerve degeneration disease selected from the group consisting of stroke; diabetic complication selected from the group consisting of diabetic nerve disorder and diabetic nephropathy; vascular endothelial cell disease which is restenosis after PTCA (percutaneous transluminal coronary angiopathy); and heart disease selected from the group consisting of dilated cardiomyopathy; comprising administering to a patient in need of treatment an effective amount of (E)-[5-[2-[1-phenyl-1-(3-pyridyl)methylideneaminoxy]ethyl]-7, 8-dihydronaphthalen-1-yloxy]acetic acid or a salt thereof.